About SpectroCon

SpectroCon was founded in 2002 by AutoFlow inventors Drs. Nadine Connor, Michael Conforti, and Gregory Hartig in direct response to a recognized need within the medical industry for a solution to the problem of postsurgical venous congestion. SpectroCon develops and commercializes AutoFlow, a medical device for the treatment of a serious complication of reconstructive surgery known as venous congestion. Currently, SpectroCon is focusing 100% of its efforts on the development of breakthrough technology and has no commercially available products or sales.

The SpectroCon team has significant knowledge and expertise in the areas of vascular physiology, reconstructive microsurgery, and business administration. In our partnership with the Wisconsin Alumni Research Foundation (WARF), we have a patent pending on our blood removal technology. We are dedicated to providing patients with an effective alternative to postsurgical leech therapy that is geared toward restoration of tissue function.

Contact us:

SpectroCon, LLC
2701 Van Hise Avenue
Madison, WI 53705
Phone: (608) 217-4192
FAX: (608) 233-6694
Email: info@spectrocon.com

SpectroCon Team

	Gregory Hartig, MD Gregory Hartig, MD, is Chair of SpectroCon's Scientific Advisory Board and Associate Professor, Otolaryngology-Head and Neck Surgery, University of Wisconsin–Madison. Dr. Hartig is a fellowship-trained head and neck reconstructive surgeon with 20 years of clinical experience. He was the primary inventor of AutoFlow, along with Dr. Connor and Dr. Michael Conforti, DVM, MBA.
	Nadine Connor, PhD Nadine Connor, PhD, is President of SpectroCon, and Assistant Professor, Otolaryngology-Head and Neck Surgery and Department of Communicative Disorders, University of Wisconsin–Madison. Dr. Connor is an NIH-funded scientist with 20 years of research experience in physiology, health outcomes, and human subjects regulatory compliance. Under Dr. Connor's leadership, SpectroCon has assembled an outstanding research team, and made great strides in venous congestion research, AutoFlow design, and product development.
	John Russell, MS John Russell, MS, is SpectroCon's Director of Research. He is a vascular physiologist who has led the company's studies of tissue survival and blood flow, and the development of AutoFlow.
	John Grade, PhD John Grade, PhD, is a Research Associate, Electrical and Computer Engineering, University of Wisconsin–Madison. He serves as the mechanical engineer for AutoFlow.
	William Hogoboom (www.willhogoboom.com) William Hogoboom, CPA, is Chief Financial Officer and Director of Manufacturing for SpectroCon. Mr. Hogoboom provides business management and strategic planning services, and directs SpectroCon's manufacturing outsource program. He has over 20 years of business experience, including manufacturing outsource management, business administration, budgetary support, and federal compliance for many other SBIR-funded projects in high-technology industries.
	Glen Leverson, PhD Glen Leverson, PhD, is a biostatistician at the University of Wisconsin Department of Surgery and provides biostatistical consulting services to SpectroCon via a subcontract with the University.
	Morris Waxler, PhD Morris Waxler, PhD, is FDA Affairs Regulatory Specialist at the law firm of LaFollette, Godfrey, and Kahn, in Madison, Wisconsin. He was formerly employed by the FDA for 26 years, including services as a Branch Chief overseeing medical devices.